Summary
ImpediMed Limited (IPD) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has ImpediMed Limited ever had a stock split?
ImpediMed Limited Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Erik Anderson CEO | ASX Exchange | Q48619102 CUSIP |
| AU Country | 83 Employees | - Last Dividend | 1 Jun 2009 Last Split | 24 Oct 2007 IPO Date |
Overview
ImpediMed Limited is an innovative medical technology company based in Pinkenba, Australia, with a global outreach spanning across Australia, North America, and beyond. Founded in 1999, the company specializes in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) devices alongside software services. These devices are pivotal in the non-invasive assessment of body composition, fluid status, and the specific medical condition of lymphedema. ImpediMed's mission revolves around delivering cutting-edge solutions that cater to various sectors within the healthcare industry, including hospitals and clinics, thereby playing a crucial role in advancing patient care and treatment outcomes.
Products and Services
- SOZO:
- SFB7:
- ImpediVET:
A flagship product of ImpediMed, SOZO, is a state-of-the-art noninvasive BIS device designed for the comprehensive assessment of lymphedema. Beyond its primary function, SOZO provides a quick snapshot of a patient's fluid status and tissue composition, which is invaluable for healthcare providers in managing and treating conditions related to fluid imbalance and tissue composition. This technology underscores ImpediMed's commitment to innovative solutions that enhance patient care and health management.
The SFB7 is another offering from ImpediMed’s portfolio, aimed at analyzing body composition in healthy individuals. As a single-channel, tetrapolar BIS device, it exemplifies the fusion of technology and healthcare to deliver accurate, valuable insights into body composition. This device is particularly geared towards use in wellness and fitness settings, marking ImpediMed’s expansion into diverse healthcare facets.
Expanding the utility of its BIS technology, ImpediMed has ventured into veterinary care with the introduction of ImpediVET. This single-channel, tetrapolar BIS device is crafted for veterinary applications, measuring fluid status and tissue composition in animals. ImpediVET signifies ImpediMed’s innovative approach to healthcare, tailoring its cutting-edge technology for use in veterinary practices, thereby contributing to the enhancement of animal care and treatment.
